AT396936B - Hybridoma zell-linien und verfahren zu ihrer herstellung sowie die verwendung der genannten zell-linien zur herstellung von monoklonalen antikörpern - Google Patents

Hybridoma zell-linien und verfahren zu ihrer herstellung sowie die verwendung der genannten zell-linien zur herstellung von monoklonalen antikörpern Download PDF

Info

Publication number
AT396936B
AT396936B AT0135886A AT135886A AT396936B AT 396936 B AT396936 B AT 396936B AT 0135886 A AT0135886 A AT 0135886A AT 135886 A AT135886 A AT 135886A AT 396936 B AT396936 B AT 396936B
Authority
AT
Austria
Prior art keywords
cell
cell line
hybridoma
human
antibody
Prior art date
Application number
AT0135886A
Other languages
German (de)
English (en)
Other versions
ATA135886A (de
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of ATA135886A publication Critical patent/ATA135886A/de
Application granted granted Critical
Publication of AT396936B publication Critical patent/AT396936B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/166—Animal cells resulting from interspecies fusion

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT0135886A 1985-05-23 1986-05-22 Hybridoma zell-linien und verfahren zu ihrer herstellung sowie die verwendung der genannten zell-linien zur herstellung von monoklonalen antikörpern AT396936B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73719685A 1985-05-23 1985-05-23

Publications (2)

Publication Number Publication Date
ATA135886A ATA135886A (de) 1993-05-15
AT396936B true AT396936B (de) 1993-12-27

Family

ID=24962960

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0135886A AT396936B (de) 1985-05-23 1986-05-22 Hybridoma zell-linien und verfahren zu ihrer herstellung sowie die verwendung der genannten zell-linien zur herstellung von monoklonalen antikörpern

Country Status (22)

Country Link
JP (2) JPS61271982A ( )
KR (1) KR900007950B1 ( )
AT (1) AT396936B ( )
AU (1) AU603985B2 ( )
BE (1) BE904811A ( )
CH (1) CH670098B ( )
CY (1) CY1644A ( )
DE (1) DE3616324C2 ( )
DK (1) DK240286A ( )
FI (1) FI93469C ( )
FR (1) FR2587357B1 ( )
GB (1) GB2175918B ( )
HK (1) HK37792A ( )
IE (1) IE59184B1 ( )
IL (1) IL78871A ( )
IT (1) IT1203789B ( )
LU (1) LU86437A1 ( )
NL (1) NL8601263A ( )
NZ (1) NZ216251A ( )
SE (1) SE8602288L ( )
SG (1) SG32392G ( )
ZA (1) ZA863871B ( )

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646041A (en) * 1987-02-12 1997-07-08 Harfeldt; Elisabeth Monoclonal antibody to herpes simplex virus and cell line producing same
IT1226477B (it) * 1988-07-04 1991-01-16 Genetik Mab S R L Linee cellulari n omas quale un mezzo per immortalare cellule produttrici di sostanze di qualunque specie animale.

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0068763A2 (en) * 1981-07-01 1983-01-05 Board Of Regents, The University Of Texas System Recombinant monoclonal antibodies
GB2113715A (en) * 1982-01-22 1983-08-10 Sandoz Ltd Process for the production of human mono-clonal antibodies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4381292A (en) * 1980-11-14 1983-04-26 The Board Of Trustees Of The Leland Stanford Jr. University Anti-human T-lymphocyte monoclonal antibody
DE3330160A1 (de) * 1983-08-20 1985-03-07 Boehringer Ingelheim KG, 6507 Ingelheim Monoklonaler antikoerper mit hoher affinitaet zum digoxin
US4777245A (en) * 1984-01-06 1988-10-11 Genelabs Incorporated Non-human primate monoclonal antibodies and methods
US4746612A (en) * 1984-10-12 1988-05-24 Scripps Clinic & Research Foundation Aotus interspecies hybridomas and monoclonal receptors produced thereby

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0068763A2 (en) * 1981-07-01 1983-01-05 Board Of Regents, The University Of Texas System Recombinant monoclonal antibodies
GB2113715A (en) * 1982-01-22 1983-08-10 Sandoz Ltd Process for the production of human mono-clonal antibodies

Also Published As

Publication number Publication date
IT1203789B (it) 1989-02-23
FR2587357A1 (fr) 1987-03-20
FI93469B (fi) 1994-12-30
CH670098B ( ) 1989-05-12
SG32392G (en) 1992-05-15
FI93469C (fi) 1995-04-10
HK37792A (en) 1992-06-04
GB2175918A (en) 1986-12-10
BE904811A (fr) 1986-11-24
SE8602288L (sv) 1986-11-24
KR900007950B1 (ko) 1990-10-23
FI862131A0 (fi) 1986-05-21
IL78871A (en) 1991-06-30
AU5764086A (en) 1986-11-27
CY1644A (en) 1992-11-06
FI862131A (fi) 1986-11-24
DK240286A (da) 1986-11-24
IT8648048A0 (it) 1986-05-23
SE8602288D0 (sv) 1986-05-21
GB8612160D0 (en) 1986-06-25
NZ216251A (en) 1989-11-28
LU86437A1 (fr) 1986-12-02
DK240286D0 (da) 1986-05-22
JPH0841100A (ja) 1996-02-13
DE3616324A1 (de) 1986-11-27
IL78871A0 (en) 1986-09-30
ZA863871B (en) 1988-01-27
AU603985B2 (en) 1990-12-06
ATA135886A (de) 1993-05-15
KR860009125A (ko) 1986-12-20
GB2175918B (en) 1989-06-28
IE59184B1 (en) 1994-01-26
FR2587357B1 (fr) 1989-10-27
DE3616324C2 (de) 1995-03-09
IE861347L (en) 1986-11-23
NL8601263A (nl) 1986-12-16
JPS61271982A (ja) 1986-12-02

Similar Documents

Publication Publication Date Title
DE3301249C2 ( )
EP0134552B1 (de) Monoklonaler Antikörper mit hoher Affinität zum Digoxin
DE3631229A1 (de) Monoklonale antikoerper gegen humanen tumornekrosefaktor (tnf) und deren verwendung
AT400577B (de) Verfahren zur herstellung eines monoklonalen antikörpers und verfahren zum nachweisen von malignen zellen
DE69634092T2 (de) Herstellung von antikörpern
EP0480440A1 (de) Monoklonale Antikörper gegen Melanom
EP0584715A2 (de) Gewinnung und Kultivierung transformierter Zellen und Herstellung gegen sie gerichteter Antikörper
EP0499176B1 (de) Monoklonale Antikörper gegen humane Pankreas-Inselzellen
LV11042B (en) METHOD FOR PRODUCING OF PERMANENT ANIMAL AND HUMAN CELL LINES AND USE THEREOFL ACARICIDALLY ACTIVE TETRAZINE DERIVATIVESrylpirrole
DE3222084A1 (de) Monoklonale antikoerper
EP0340604A2 (de) Monoklonaler Antikörper und seine Verwendung
CH683526A5 (de) Zellinie für die Herstellung von Antikörper bildenden Hybridomen, Verfahren zur Herstellung einer menschlichen Zellinie und Antikörper produzierendes Hybridom.
AT396936B (de) Hybridoma zell-linien und verfahren zu ihrer herstellung sowie die verwendung der genannten zell-linien zur herstellung von monoklonalen antikörpern
DE69434024T2 (de) Auf humanen cortikalen thymozyten exprimierte oberflächenproteine und ihre verwendung
AT395017B (de) Verfahren zur herstellung eines neuen lymphokins (lk 2) sowie verwendung von lk 2 zur herstellung eines pharmazeutischen praeparates
DE3325131C2 ( )
DE3509958A1 (de) Monoklonale antikoerper gegen atriale, natriuretische peptide vom menschen
DE3239863C2 (de) Verfahren zur Herstellung eines subkultivierbaren Lymphokin-bildenden Human-T-Zell-Hybridoms
EP0937254A2 (de) VERFAHREN ZUR INDIREKTEN BESTIMMUNG DER TYP I INTERFERON-PRODUKTION IN VIVO MITTELS ANTIKÖRPER GEGEN HUMANE Mx-PROTEINE SOWIE ANTIKÖRPER HIERZU
DE3810331A1 (de) Monoklonale vac-antikoerper
DE3329449A1 (de) Monoklonaler antikoerper, der eine struktur erkennt, die dem human-interleukin-2 (tcgf) und der leichten kette (lambda) von humanimmunglobulin gemeinsam ist, und hybridoma-zell-linien, die diese monoklonalen antikoerper produzieren
EP0529348A1 (de) Verfahren zur Reinigung von Faktor XIII, monoklonale Antikörper gegen Faktor XIIIA, ihre Herstellung und Verwendung
EP0168745A2 (de) Monoklonale Antikörper gegen humanes IFN-gamma, diese Antikörper produzierende Hybridzellinien, Verwendung der neuen Antikörper und Verfahren zu deren Herstellung
DE3508307A1 (de) Monoklonale antikoerper gegen digoxin
CH668775A5 (en) Highly stable hybridomaoma cell line for antibody prodn. - made by fusing secreting cell with compatible xenogeneic hybrid as immortalising component

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
ELJ Ceased due to non-payment of the annual fee